Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Neurology
Published in: BMC Neurology 1/2017

Open Access 01-12-2017 | Research article

Mindfulness-based stress reduction for people with multiple sclerosis – a feasibility randomised controlled trial

Authors: Robert Simpson, Frances S. Mair, Stewart W. Mercer

Published in: BMC Neurology | Issue 1/2017

Login to get access

Abstract

Background

Multiple sclerosis (MS) is a stressful condition. Mental health comorbidity is common. Stress can increase the risk of depression, reduce quality of life (QOL), and possibly exacerbate disease activity in MS. Mindfulness-Based Stress Reduction (MBSR) may help, but has been little studied in MS, particularly among more disabled individuals.

Methods

The objective of this study was to test the feasibility and likely effectiveness of a standard MBSR course for people with MS. Participant eligibility included: age > 18, any type of MS, an Expanded Disability Status Scale (EDSS) </= 7.0. Participants received either MBSR or wait-list control. Outcome measures were collected at baseline, post-intervention, and three-months later. Primary outcomes were perceived stress and QOL. Secondary outcomes were common MS symptoms, mindfulness, and self-compassion.

Results

Fifty participants were recruited and randomised (25 per group). Trial retention and outcome measure completion rates were 90% at post-intervention, and 88% at 3 months. Sixty percent of participants completed the course. Immediately post-MBSR, perceived stress improved with a large effect size (ES 0.93; p < 0.01), compared to very small beneficial effects on QOL (ES 0.17; p = 0.48). Depression (ES 1.35; p < 0.05), positive affect (ES 0.87; p = 0.13), anxiety (ES 0.85; p = 0.05), and self-compassion (ES 0.80; p < 0.01) also improved with large effect sizes. At three-months post-MBSR (study endpoint) improvements in perceived stress were diminished to a small effect size (ES 0.26; p = 0.39), were negligible for QOL (ES 0.08; p = 0.71), but were large for mindfulness (ES 1.13; p < 0.001), positive affect (ES 0.90; p = 0.54), self-compassion (ES 0.83; p < 0.05), anxiety (ES 0.82; p = 0.15), and prospective memory (ES 0.81; p < 0.05).

Conclusions

Recruitment, retention, and data collection demonstrate that a RCT of MBSR is feasible for people with MS. Trends towards improved outcomes suggest that a larger definitive RCT may be warranted. However, optimisation changes may be required to render more stable the beneficial treatment effects on stress and depression.

Trial registration

ClinicalTrials.gov Identifier NCT02136485; trial registered 1st May 2014.
Appendix
Available only for authorised users
Literature
1.
Dennison L, Moss-Morris R, Chalder T. A review of psychological correlates of adjustment in patients with multiple sclerosis. Clin Psychol Rev. 2009;29(2):141–53.CrossRefPubMed
2.
Marrie RA, et al. The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review. Mult Scler J. 2015;21(3):305–17.
3.
4.
5.
Artemiadis AK, Anagnostouli MC, Alexopoulos EC. Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review. Neuroepidemiology. 2011;36(2):109–20.CrossRefPubMed
6.
McEwen BS, Getz L. Lifetime experiences, the brain and personalized medicine: An integrative perspective. Metabolism. 2013;62:S20–6.CrossRefPubMed
7.
McEwen BS. Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol. 2008;583(2):174–85.CrossRefPubMedPubMedCentral
8.
Salehpoor G, Rezaei S, Hosseininezhad M. Quality of life in multiple sclerosis (MS) and role of fatigue, depression, anxiety, and stress: A bicenter study from north of Iran. Iranian journal of nursing and midwifery research. 2014;19(6):593.PubMedPubMedCentral
9.
10.
Fiest K, et al. Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis. Multiple Sclerosis and Related Disorders. 2016;5:12–26.CrossRefPubMed
11.
Reynard AK, Sullivan AB, Rae-Grant A. A Systematic Review of Stress-Management Interventions for Multiple Sclerosis Patients. International journal of MS care. 2014;16(3):140–4.CrossRefPubMedPubMedCentral
12.
Goyal M, et al. Meditation programs for psychological stress and well-being: a systematic review and meta-analysis. JAMA Intern Med. 2014;174(3):357–68.CrossRefPubMedPubMedCentral
13.
MRC U. Developing and evaluating complex interventions: new guidance. London: Medical Research Council; 2008.
14.
Kabat-Zinn J. Wherever you go, there you are: Mindfulness meditation in everyday life. Hyperion. 1994;4.
15.
Tang Y-Y, Hölzel BK, Posner MI. The neuroscience of mindfulness meditation. Nat Rev Neurosci. 2015;16(4):213–25.CrossRefPubMed
16.
Hölzel BK, et al. How does mindfulness meditation work? Proposing mechanisms of action from a conceptual and neural perspective. Perspect Psychol Sci. 2011;6(6):537–59.CrossRefPubMed
17.
Kabat-Zinn J. An outpatient program in behavioral medicine for chronic pain patients based on the practice of mindfulness meditation: Theoretical considerations and preliminary results. Gen Hosp Psychiatry. 1982;4(1):33–47.CrossRefPubMed
18.
Fjorback L, et al. Mindfulness-Based Stress Reduction and Mindfulness-Based Cognitive Therapy–a systematic review of randomized controlled trials. Acta Psychiatr Scand. 2011;124(2):102–19.CrossRefPubMed
19.
Lakhan SE, Schofield KL. Mindfulness-based therapies in the treatment of somatization disorders: a systematic review and meta-analysis. PLoS One. 2013;8(8):e71834.CrossRefPubMedPubMedCentral
20.
21.
Bogosian A, et al. Distress improves after mindfulness training for progressive MS: A pilot randomised trial. Mult Scler J. 2015;21(9):1184–94.
22.
Bogosian A, et al. Potential treatment mechanisms in a mindfulness based intervention for people with progressive multiple sclerosis. Br J Health Psychol. 2016;21(4):859–80.
23.
Burschka JM, et al. Mindfulness-based interventions in multiple sclerosis: beneficial effects of Tai Chi on balance, coordination, fatigue and depression. BMC Neurol. 2014;14(1):165.CrossRefPubMedPubMedCentral
24.
25.
Kolahkaj B, Zargar F. Effect of Mindfulness-Based Stress Reduction on Anxiety, Depression and Stress in Women With Multiple Sclerosis. Nursing and Midwifery Studies. 2015:4(4).
26.
Mills N, Allen J. Mindfulness of movement as a coping strategy in multiple sclerosis: a pilot study. Gen Hosp Psychiatry. 2000;22(6):425–31.CrossRefPubMed
27.
Tavee J, et al. Effects of meditation on pain and quality of life in multiple sclerosis and peripheral neuropathy: A pilot study. International journal of MS care. 2011;13(4):163–8.CrossRefPubMedPubMedCentral
28.
Carmody J, Baer RA. How long does a mindfulness-based stress reduction program need to be? A review of class contact hours and effect sizes for psychological distress. J Clin Psychol. 2009;65(6):627–38.CrossRefPubMed
29.
Bellg AJ, et al. Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change Consortium. Health Psychol. 2004;23(5):443.CrossRefPubMed
30.
Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983:385–96.
31.
Janssen M, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2013;22(7):1717–27.CrossRefPubMed
32.
Ritvo P, et al. MSQLI—Multiple Sclerosis Quality of Life Inventory, A user’s manual. New York: National MS Society; 1997.
33.
Brown KW, Ryan RM. The benefits of being present: mindfulness and its role in psychological well-being. J Pers Soc Psychol. 2003;84(4):822.CrossRefPubMed
34.
Raes F, et al. Construction and factorial validation of a short form of the self-compassion scale. Clinical psychology & psychotherapy. 2011;18(3):250–5.CrossRef
35.
Newsom-Davis I, et al. The emotional lability questionnaire: a new measure of emotional lability in amyotrophic lateral sclerosis. J Neurol Sci. 1999;169(1):22–5.CrossRefPubMed
36.
Carstairs V, Morris R. Deprivation and health in Scotland. Health Bull. 1990;48(4):162–75.
37.
Browne RH. On the use of a pilot sample for sample size determination. Stat Med. 1995;14(17):1933–40.CrossRefPubMed
38.
Mathew KL, et al. The long-term effects of mindfulness-based cognitive therapy as a relapse prevention treatment for major depressive disorder. Behav Cogn Psychother. 2010;38(5):561–76.CrossRefPubMed
39.
Gu J, et al. How do mindfulness-based cognitive therapy and mindfulness-based stress reduction improve mental health and wellbeing? A systematic review and meta-analysis of mediation studies. Clin Psychol Rev. 2015;37:1–12.CrossRefPubMed
40.
Schirda, B., J.A. Nicholas, and R.S. Prakash, Examining Trait Mindfulness, Emotion Dysregulation, and Quality of Life in Multiple Sclerosis. 2015.
41.
Senders A, et al. Perceived Stress in Multiple Sclerosis The Potential Role of Mindfulness in Health and Well-Being. Journal of evidence-based complementary & alternative medicine. 2014;19(2):104–11.CrossRef
42.
Pakenham KI, Samios C. Couples coping with multiple sclerosis: A dyadic perspective on the roles of mindfulness and acceptance. J Behav Med. 2013;36(4):389–400.CrossRefPubMed
43.
Sirois FM, Molnar DS, Hirsch JK. Self-Compassion, Stress, and Coping in the Context of Chronic Illness. Self Identity. 2015;14(3):334–47.CrossRef
44.
Simpson RJ, et al. Physical and mental health comorbidity is common in people with multiple sclerosis: nationally representative cross-sectional population database analysis. BMC Neurol. 2014;14(1):128.CrossRefPubMedPubMedCentral
45.
Mackenzie C, Gekoski W, Knox V. Age, gender, and the underutilization of mental health services: the influence of help-seeking attitudes. Aging and Mental Health. 2006;10(6):574–82.CrossRefPubMed
46.
47.
Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. The Lancet Neurology. 2008;7(12):1139–51.CrossRefPubMed
48.
49.
Kurtzke, J.F., Rating neurologic impairment in multiple sclerosis an expanded disability status scale (EDSS). Neurology, 1983. 33(11): p. 1444–4.
Metadata
Title
Mindfulness-based stress reduction for people with multiple sclerosis – a feasibility randomised controlled trial
Authors
Robert Simpson
Frances S. Mair
Stewart W. Mercer
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2017
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-017-0880-8

Other articles of this Issue 1/2017

BMC Neurology 1/2017 Go to the issue

Research article

Peripheral blood lymphocytes immunophenotyping predicts disease activity in clinically isolated syndrome patients

Case report

A novel frameshift GRN mutation results in frontotemporal lobar degeneration with a distinct clinical phenotype in two siblings: case report and literature review

Research article

Relationship between serum uric acid level and mild cognitive impairment in Chinese community elderly

Case report

Anterior sacral meningocele infected with Fusobacterium in a patient with recently diagnosed colorectal carcinoma – a case report

Case report

Conjugal amyotrophic lateral sclerosis: a case report from Scotland

Research article

Plaque distribution of low-grade basilar artery atherosclerosis and its clinical relevance